Diagnostic Evaluations of Autism Spectrum Disorder during the COVID-19 Pandemic

• Type of Material: Article
• Authors: Jina Jang, Thompson Autism Center; Stormi White, Emory University; Amy N. Esler, University of Minnesota; So Hyun Kim, New York Presbyterian Hospital; Cheryl Klaiman, Emory University; Jonathan T. Megerian, Thompson Autism Center; Amy Morse, Thompson Autism Center; Cy Nadler, Childrens Mercy Kansas City; Stephen M. Kanne, New York Presbyterian Hospital
• Language: English
• Date: 2021-03-17
• Publisher: SPRINGER/PLENUM PUBLISHERS
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
• Final Published Version (URL): http://dx.doi.org/10.1007/s10803-021-04960-7
• Title of Journal or Parent Work: JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
• Volume: 52
• Issue: 2
• Start Page: 962
• End Page: 973
• Keywords: Autism; COVID-19; Psychology; Psychology, Developmental; Social Sciences; Diagnostic evaluations
• Research Categories: Health Sciences, Public Health; Psychology, Cognitive; Psychology, Developmental

Abstract

A global pandemic has significantly impacted the ability to conduct diagnostic evaluations for autism spectrum disorder (ASD). In the wake of the coronavirus, autism centers and providers quickly needed to implement innovative diagnostic processes to adapt in order to continue serve patient needs while minimizing the spread of the virus. The International Collaborative for Diagnostic Evaluation of Autism (IDEA) is a grassroots organization that came together to discuss standards of care during the pandemic and to provide a forum wherein providers communicated decisions. This white paper is intended to provide examples of how different centers adjusted their standard approaches to conduct diagnostic evaluations for ASD during the pandemic and to provide insight to other centers as they go through similar challenges.